{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:44:46Z","timestamp":1794091486500,"version":"4.8.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05462-8","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T07:46:51Z","timestamp":1763711211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Curcumin Ameliorates Depressive-like Behaviors by Modulating mGluR2\/PGC-1\u03b1-Mediated Glutamatergic Homeostasis and Mitochondrial Function"],"prefix":"10.1007","volume":"63","author":[{"given":"Liping","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conghua","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Rui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"6","key":"5462_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1192\/bjp.2023.9","volume":"222","author":"P Cuijpers","year":"2023","unstructured":"Cuijpers P, Javed A, Bhui K (2023) The WHO world mental health report: a call for action. Br J Psychiatry 222(6):227\u2013229. https:\/\/doi.org\/10.1192\/bjp.2023.9","journal-title":"Br J Psychiatry"},{"key":"5462_CR2","volume-title":"World health statistics 2025: monitoring health for the SDGs","author":"WH Organization","year":"2025","unstructured":"Organization WH (2025) World health statistics 2025: monitoring health for the SDGs. WHO, Sustainable Development Goals"},{"issue":"3","key":"5462_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/wps.21018","volume":"21","author":"M Freeman","year":"2022","unstructured":"Freeman M (2022) The world mental health report: transforming mental health for all. World Psychiatry 21(3):391\u2013392. https:\/\/doi.org\/10.1002\/wps.21018","journal-title":"World Psychiatry"},{"key":"5462_CR4","doi-asserted-by":"publisher","first-page":"04160","DOI":"10.7189\/jogh.13.04160","volume":"13","author":"Y Huang","year":"2023","unstructured":"Huang Y, Li Y, Pan H, Han L (2023) Global, regional, and national burden of neurological disorders in 204 countries and territories worldwide. J Glob Health 13:04160. https:\/\/doi.org\/10.7189\/jogh.13.04160","journal-title":"J Glob Health"},{"issue":"5","key":"5462_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"Collaborators GBDN","year":"2019","unstructured":"Collaborators GBDN (2019) Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(5):459\u2013480. https:\/\/doi.org\/10.1016\/S1474-4422(18)30499-X","journal-title":"Lancet Neurol"},{"key":"5462_CR6","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.jad.2020.12.148","volume":"282","author":"K Nakagome","year":"2021","unstructured":"Nakagome K, Yokoi Y, Nakagawa A, Tani M, Nishioka G, Yoshimura N, Furukawa TA, Watanabe K et al (2021) Acceptability of escitalopram versus duloxetine in outpatients with depression who did not respond to initial second-generation antidepressants: a randomized, parallel-group, non-inferiority trial. J Affect Disord 282:1011\u20131020. https:\/\/doi.org\/10.1016\/j.jad.2020.12.148","journal-title":"J Affect Disord"},{"issue":"1","key":"5462_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/cpt.2903","volume":"114","author":"CA Bousman","year":"2023","unstructured":"Bousman CA, Stevenson JM, Ramsey LB, Sangkuhl K, Hicks JK, Strawn JR, Singh AB, Ruano G et al (2023) Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A genotypes and serotonin reuptake inhibitor antidepressants. Clin Pharmacol Ther 114(1):51\u201368. https:\/\/doi.org\/10.1002\/cpt.2903","journal-title":"Clin Pharmacol Ther"},{"key":"5462_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.psyneuen.2018.12.010","volume":"102","author":"SA Kinlein","year":"2019","unstructured":"Kinlein SA, Phillips DJ, Keller CR, Karatsoreos IN (2019) Role of corticosterone in altered neurobehavioral responses to acute stress in a model of compromised hypothalamic-pituitary-adrenal axis function. Psychoneuroendocrinology 102:248\u2013255. https:\/\/doi.org\/10.1016\/j.psyneuen.2018.12.010","journal-title":"Psychoneuroendocrinology"},{"key":"5462_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081929","author":"IB Kim","year":"2022","unstructured":"Kim IB, Lee JH, Park SC (2022) The relationship between stress, inflammation, and depression. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10081929","journal-title":"Biomedicines"},{"issue":"7843","key":"5462_CR10","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41586-020-03083-w","volume":"589","author":"YQ Ping","year":"2021","unstructured":"Ping YQ, Mao C, Xiao P, Zhao RJ, Jiang Y, Yang Z, An WT, Shen DD et al (2021) Structures of the glucocorticoid-bound adhesion receptor GPR97-G(o) complex. Nature 589(7843):620\u2013626. https:\/\/doi.org\/10.1038\/s41586-020-03083-w","journal-title":"Nature"},{"issue":"1","key":"5462_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neuron.2019.03.013","volume":"102","author":"RS Duman","year":"2019","unstructured":"Duman RS, Sanacora G, Krystal JH (2019) Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron 102(1):75\u201390. https:\/\/doi.org\/10.1016\/j.neuron.2019.03.013","journal-title":"Neuron"},{"issue":"1","key":"5462_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/npp.2016.199","volume":"42","author":"E Haroon","year":"2017","unstructured":"Haroon E, Miller AH, Sanacora G (2017) Inflammation, glutamate, and glia: a trio of trouble in mood disorders. Neuropsychopharmacology 42(1):193\u2013215. https:\/\/doi.org\/10.1038\/npp.2016.199","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"5462_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1017\/S1461145712000016","volume":"16","author":"V Duric","year":"2013","unstructured":"Duric V, Banasr M, Stockmeier CA, Simen AA, Newton SS, Overholser JC, Jurjus GJ, Dieter L et al (2013) Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects. Int J Neuropsychopharmacol 16(1):69\u201382. https:\/\/doi.org\/10.1017\/S1461145712000016","journal-title":"Int J Neuropsychopharmacol"},{"key":"5462_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107875","volume":"226","author":"CY Xia","year":"2021","unstructured":"Xia CY, He J, Du LD, Yan Y, Lian WW, Xu JK, Zhang WK (2021) Targeting the dysfunction of glutamate receptors for the development of novel antidepressants. Pharmacol Ther 226:107875. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107875","journal-title":"Pharmacol Ther"},{"issue":"11","key":"5462_CR15","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.biopsych.2017.11.021","volume":"83","author":"AJ Cross","year":"2018","unstructured":"Cross AJ, Anthenelli R, Li X (2018) Metabotropic glutamate receptors 2 and 3 as targets for treating nicotine addiction. Biol Psychiatry 83(11):947\u2013954. https:\/\/doi.org\/10.1016\/j.biopsych.2017.11.021","journal-title":"Biol Psychiatry"},{"issue":"2","key":"5462_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.pnpbp.2009.11.018","volume":"34","author":"AM Feyissa","year":"2010","unstructured":"Feyissa AM, Woolverton WL, Miguel-Hidalgo JJ, Wang Z, Kyle PB, Hasler G, Stockmeier CA, Iyo AH et al (2010) Elevated level of metabotropic glutamate receptor 2\/3 in the prefrontal cortex in major depression. Prog Neuropsychopharmacol Biol Psychiatry 34(2):279\u2013283. https:\/\/doi.org\/10.1016\/j.pnpbp.2009.11.018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"5462_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jad.2015.10.004","volume":"190","author":"CE McOmish","year":"2016","unstructured":"McOmish CE, Pavey G, Gibbons A, Hopper S, Udawela M, Scarr E, Dean B (2016) Lower [3H]LY341495 binding to mGlu2\/3 receptors in the anterior cingulate of subjects with major depressive disorder but not bipolar disorder or schizophrenia. J Affect Disord 190:241\u2013248. https:\/\/doi.org\/10.1016\/j.jad.2015.10.004","journal-title":"J Affect Disord"},{"issue":"10","key":"5462_CR18","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1038\/s41386-019-0380-1","volume":"44","author":"JN Highland","year":"2019","unstructured":"Highland JN, Zanos P, Georgiou P, Gould TD (2019) Group II metabotropic glutamate receptor blockade promotes stress resilience in mice. Neuropsychopharmacology 44(10):1788\u20131796. https:\/\/doi.org\/10.1038\/s41386-019-0380-1","journal-title":"Neuropsychopharmacology"},{"key":"5462_CR19","doi-asserted-by":"publisher","unstructured":"Jorge GJ, Nebiyou M, Alkaslasi MR, Somasundaran P, Slavutsky AL, Ward ME, Watkins TA, Le Pichon CE (2023) DLK-dependent mitochondrial fission drives axon degeneration and neuronal cell death. bioRxiv : the preprint server for biology. https:\/\/doi.org\/10.1101\/2023.01.30.526132","DOI":"10.1101\/2023.01.30.526132"},{"issue":"12","key":"5462_CR20","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1038\/s42255-023-00924-6","volume":"5","author":"WT Dong","year":"2023","unstructured":"Dong WT, Long LH, Deng Q, Liu D, Wang JL, Wang F, Chen JG (2023) Mitochondrial fission drives neuronal metabolic burden to promote stress susceptibility in male mice. Nat Metab 5(12):2220\u20132236. https:\/\/doi.org\/10.1038\/s42255-023-00924-6","journal-title":"Nat Metab"},{"key":"5462_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2020.113236","volume":"229","author":"C Yang","year":"2021","unstructured":"Yang C, Sui G, Li D, Wang L, Zhang S, Lei P, Chen Z, Wang F (2021) Exogenous IGF-1 alleviates depression-like behavior and hippocampal mitochondrial dysfunction in high-fat diet mice. Physiol Behav 229:113236. https:\/\/doi.org\/10.1016\/j.physbeh.2020.113236","journal-title":"Physiol Behav"},{"issue":"3","key":"5462_CR22","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1007\/s12035-020-02163-2","volume":"58","author":"N Dreumont","year":"2021","unstructured":"Dreumont N, Mimoun K, Pourie C, Quadros EV, Alberto JM, Umoret R, Helle D, Robert A et al (2021) Glucocorticoid receptor activation restores learning memory by modulating hippocampal plasticity in a mouse model of brain vitamin B(12) deficiency. Mol Neurobiol 58(3):1024\u20131035. https:\/\/doi.org\/10.1007\/s12035-020-02163-2","journal-title":"Mol Neurobiol"},{"key":"5462_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-025-00706-9","author":"I Schmitz","year":"2025","unstructured":"Schmitz I, Bobermin LD, da Silva A, Weber FB, Thomaz NK, Schmitz F, Brondani M, Fachinetto R, et al. (2025) A single dose of haloperidol decanoate induces short-term hippocampal neuroinflammation: focus on the glial response. Pharmacol Rep. https:\/\/doi.org\/10.1007\/s43440-025-00706-9","journal-title":"Pharmacol Rep"},{"issue":"1","key":"5462_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-017-1922-x","volume":"17","author":"XS Wang","year":"2017","unstructured":"Wang XS, Zhang ZR, Zhang MM, Sun MX, Wang WW, Xie CL (2017) Neuroprotective properties of curcumin in toxin-base animal models of Parkinson\u2019s disease: a systematic experiment literatures review. BMC Complement Altern Med 17(1):412. https:\/\/doi.org\/10.1186\/s12906-017-1922-x","journal-title":"BMC Complement Altern Med"},{"key":"5462_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.572533","volume":"11","author":"T Ramaholimihaso","year":"2020","unstructured":"Ramaholimihaso T, Bouazzaoui F, Kaladjian A (2020) Curcumin in depression: potential mechanisms of action and current evidence-a narrative review. Front Psychiatry 11:572533. https:\/\/doi.org\/10.3389\/fpsyt.2020.572533","journal-title":"Front Psychiatry"},{"issue":"2","key":"5462_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2022.152177","volume":"227","author":"L Xu","year":"2022","unstructured":"Xu L, Xie X, Li X, Duan W, Qiu L, Liu H, Luo Y (2022) Inflammatory level under different p53 mutation status and the regulation role of curcumin in tumor microenvironment. Immunobiology 227(2):152177. https:\/\/doi.org\/10.1016\/j.imbio.2022.152177","journal-title":"Immunobiology"},{"issue":"6","key":"5462_CR27","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1007\/s12011-023-03849-z","volume":"202","author":"HM Fahmy","year":"2024","unstructured":"Fahmy HM, Aboalasaad FA, Mohamed AS, Elhusseiny FA, Khadrawy YA, Elmekawy A (2024) Evaluation of the therapeutic effect of curcumin-conjugated zinc oxide nanoparticles on reserpine-induced depression in Wistar rats. Biol Trace Elem Res 202(6):2630\u20132644. https:\/\/doi.org\/10.1007\/s12011-023-03849-z","journal-title":"Biol Trace Elem Res"},{"key":"5462_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2022.136697","volume":"782","author":"S Moradi Vastegani","year":"2022","unstructured":"Moradi Vastegani S, Hajipour S, Sarkaki A, Basir Z, Parisa Navabi S, Farbood Y, Khoshnam SE (2022) Curcumin mitigates lipopolysaccharide-induced anxiety\/depression-like behaviors, blood-brain barrier dysfunction and brain edema by decreasing cerebral oxidative stress in male rats. Neurosci Lett 782:136697. https:\/\/doi.org\/10.1016\/j.neulet.2022.136697","journal-title":"Neurosci Lett"},{"key":"5462_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/nu16152414","author":"M Yaikwawong","year":"2024","unstructured":"Yaikwawong M, Jansarikit L, Jirawatnotai S, Chuengsamarn S (2024) Curcumin reduces depression in obese patients with type 2 diabetes: a randomized controlled trial. Nutrients. https:\/\/doi.org\/10.3390\/nu16152414","journal-title":"Nutrients"},{"key":"5462_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108687","volume":"196","author":"S Dogra","year":"2021","unstructured":"Dogra S, Conn PJ (2021) Targeting metabotropic glutamate receptors for the treatment of depression and other stress-related disorders. Neuropharmacology 196:108687. https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108687","journal-title":"Neuropharmacology"},{"issue":"2","key":"5462_CR31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s40263-022-00901-9","volume":"36","author":"AL Lopresti","year":"2022","unstructured":"Lopresti AL (2022) Potential role of curcumin for the treatment of major depressive disorder. CNS Drugs 36(2):123\u2013141. https:\/\/doi.org\/10.1007\/s40263-022-00901-9","journal-title":"CNS Drugs"},{"issue":"10","key":"5462_CR32","doi-asserted-by":"publisher","first-page":"5930","DOI":"10.1097\/MS9.0000000000002487","volume":"86","author":"X Wei","year":"2024","unstructured":"Wei X (2024) The glutamatergic system in the development of stress-induced depression. Ann Med Surg 86(10):5930\u20135937. https:\/\/doi.org\/10.1097\/MS9.0000000000002487","journal-title":"Ann Med Surg"},{"key":"5462_CR33","doi-asserted-by":"publisher","DOI":"10.1515\/jbcpp-2019-0016","author":"P Rana","year":"2020","unstructured":"Rana P, Bagewadi H, Banerjee BD, Bhattacharya SK, Mediratta PK (2020) Attenuation of oxidative stress and neurotoxicity involved in the antidepressant-like effect of the MK-801(dizocilpine) in Bacillus Calmette-Guerin-induced depression in mice. J Basic Clin Physiol Pharmacol. https:\/\/doi.org\/10.1515\/jbcpp-2019-0016","journal-title":"J Basic Clin Physiol Pharmacol"},{"issue":"10","key":"5462_CR34","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/s41593-023-01436-y","volume":"26","author":"T Su","year":"2023","unstructured":"Su T, Lu Y, Fu C, Geng Y, Chen Y (2023) GluN2A mediates ketamine-induced rapid antidepressant-like responses. Nat Neurosci 26(10):1751\u20131761. https:\/\/doi.org\/10.1038\/s41593-023-01436-y","journal-title":"Nat Neurosci"},{"key":"5462_CR35","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/978-981-19-7376-5_21","volume":"1411","author":"A Halaris","year":"2023","unstructured":"Halaris A, Cook J (2023) The glutamatergic system in treatment-resistant depression and comparative effectiveness of ketamine and esketamine: role of inflammation? Adv Exp Med Biol 1411:487\u2013512. https:\/\/doi.org\/10.1007\/978-981-19-7376-5_21","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"5462_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2174\/1570159X19666210916102638","volume":"21","author":"KS Abd-Elrahman","year":"2023","unstructured":"Abd-Elrahman KS, Sarasija S, Ferguson SSG (2023) The role of neuroglial metabotropic glutamate receptors in Alzheimer\u2019s disease. Curr Neuropharmacol 21(2):273\u2013283. https:\/\/doi.org\/10.2174\/1570159X19666210916102638","journal-title":"Curr Neuropharmacol"},{"key":"5462_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-024-00612-6","author":"K Stachowicz","year":"2024","unstructured":"Stachowicz K (2024) Interactions between metabotropic glutamate and CB1 receptors: implications for mood, cognition, and synaptic signaling based on data from mGluR and CB1R-targeting drugs. Pharmacol Rep. https:\/\/doi.org\/10.1007\/s43440-024-00612-6","journal-title":"Pharmacol Rep"},{"issue":"48","key":"5462_CR38","doi-asserted-by":"publisher","first-page":"14960","DOI":"10.1073\/pnas.1516016112","volume":"112","author":"C Nasca","year":"2015","unstructured":"Nasca C, Zelli D, Bigio B, Piccinin S, Scaccianoce S, Nistico R, McEwen BS (2015) Stress dynamically regulates behavior and glutamatergic gene expression in hippocampus by opening a window of epigenetic plasticity. Proc Natl Acad Sci U S A 112(48):14960\u201314965. https:\/\/doi.org\/10.1073\/pnas.1516016112","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"5462_CR39","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00424-023-02890-0","volume":"476","author":"SXH Mthembu","year":"2024","unstructured":"Mthembu SXH, Mazibuko-Mbeje SE, Ziqubu K, Muvhulawa N, Marcheggiani F, Cirilli I, Nkambule BB, Muller CJF et al (2024) Potential regulatory role of PGC-1\u03b1 within the skeletal muscle during metabolic adaptations in response to high-fat diet feeding in animal models. Pflugers Arch 476(3):283\u2013293. https:\/\/doi.org\/10.1007\/s00424-023-02890-0","journal-title":"Pflugers Arch"},{"key":"5462_CR40","doi-asserted-by":"publisher","unstructured":"Abu Shelbayeh O, Arroum T, Morris S, Busch KB (2023) PGC-1alpha is a master regulator of mitochondrial lifecycle and ROS stress response. Antioxidants 12(5). https:\/\/doi.org\/10.3390\/antiox12051075","DOI":"10.3390\/antiox12051075"},{"key":"5462_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3714857","volume":"2022","author":"H Xu","year":"2022","unstructured":"Xu H, Xing S, Lei X, Yi J, Liu S, Du Y, Yang B, Zhang N (2022) A famous Chinese medicine formula: Yinhuo decoction antagonizes the damage of corticosterone to PC12 cells and improves depression by regulating the SIRT1\/PGC-1alpha pathway. BioMed Res Int 2022:3714857. https:\/\/doi.org\/10.1155\/2022\/3714857","journal-title":"BioMed Res Int"},{"issue":"12","key":"5462_CR42","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1176\/appi.ajp.2014.14010067","volume":"171","author":"CG Abdallah","year":"2014","unstructured":"Abdallah CG, Jiang L, De Feyter HM, Fasula M, Krystal JH, Rothman DL, Mason GF, Sanacora G (2014) Glutamate metabolism in major depressive disorder. Am J Psychiatry 171(12):1320\u20131327. https:\/\/doi.org\/10.1176\/appi.ajp.2014.14010067","journal-title":"Am J Psychiatry"},{"issue":"8","key":"5462_CR43","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00702-014-1187-1","volume":"121","author":"R Dantzer","year":"2014","unstructured":"Dantzer R, Walker AK (2014) Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression? J Neural Transm 121(8):925\u2013932. https:\/\/doi.org\/10.1007\/s00702-014-1187-1","journal-title":"J Neural Transm"},{"issue":"1","key":"5462_CR44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12906-025-04798-x","volume":"25","author":"EP Hamlbar","year":"2025","unstructured":"Hamlbar EP, Mirghafourvand M, Shaseb E, Kamalifard M (2025) The effect of curcumin on postpartum depression and anxiety in primiparous women: a double-blind randomized placebo-controlled clinical trial. BMC Complement Med Ther 25(1):157. https:\/\/doi.org\/10.1186\/s12906-025-04798-x","journal-title":"BMC Complement Med Ther"},{"issue":"1","key":"5462_CR45","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1186\/s13063-024-08354-9","volume":"25","author":"M Soltani","year":"2024","unstructured":"Soltani M, Hosseinzadeh-Attar MJ, Rezaei M, Alipoor E, Vasheghani-Farahani A, Yaseri M, Rezayat SM (2024) Effect of nano-curcumin supplementation on cardiometabolic risk factors, physical and psychological quality of life, and depression in patients with coronary slow flow phenomenon: a randomized double-blind clinical trial. Trials 25(1):515. https:\/\/doi.org\/10.1186\/s13063-024-08354-9","journal-title":"Trials"},{"issue":"5","key":"5462_CR46","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1177\/0018578720925384","volume":"56","author":"AA Reyad","year":"2021","unstructured":"Reyad AA, Plaha K, Girgis E, Mishriky R (2021) Fluoxetine in the management of major depressive disorder in children and adolescents: a meta-analysis of randomized controlled trials. Hosp Pharm 56(5):525\u2013531. https:\/\/doi.org\/10.1177\/0018578720925384","journal-title":"Hosp Pharm"},{"key":"5462_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117748","volume":"182","author":"YB Lee","year":"2025","unstructured":"Lee YB, Cho YJ, Kim JK (2025) The unique role of fluoxetine in alleviating depression and anxiety by regulating gut microbiota and the expression of vagus nerve-mediated serotonin and melanocortin-4 receptors. Biomed Pharmacother 182:117748. https:\/\/doi.org\/10.1016\/j.biopha.2024.117748","journal-title":"Biomed Pharmacother"},{"key":"5462_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1060954","volume":"13","author":"S Zeb","year":"2022","unstructured":"Zeb S, Ye H, Liu Y, Du HP, Guo Y, Zhu YM, Ni Y, Zhang HL, et al. (2022) Necroptotic kinases are involved in the reduction of depression-induced astrocytes and fluoxetine\u2019s inhibitory effects on necroptotic kinases. Front Pharmacol 13:1060954. https:\/\/doi.org\/10.3389\/fphar.2022.1060954","journal-title":"Front Pharmacol"},{"key":"5462_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.pnpbp.2018.01.011","volume":"83","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Lin Z, Chen L, Ouyang L, Gu L, Chen F, Zhang Q (2018) Hippocampal astrocyte atrophy in a mouse depression model induced by corticosterone is reversed by fluoxetine instead of benzodiazepine diazepam. Prog Neuropsychopharmacol Biol Psychiatry 83:99\u2013109. https:\/\/doi.org\/10.1016\/j.pnpbp.2018.01.011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"5462_CR50","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neuropharm.2017.09.017","volume":"128","author":"AR Gobinath","year":"2018","unstructured":"Gobinath AR, Richardson RJ, Chow C, Workman JL, Lieblich SE, Barr AM, Galea LAM (2018) Voluntary running influences the efficacy of fluoxetine in a model of postpartum depression. Neuropharmacology 128:106\u2013118. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.09.017","journal-title":"Neuropharmacology"},{"issue":"1","key":"5462_CR51","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1113\/EP090761","volume":"109","author":"KJ Thompson","year":"2024","unstructured":"Thompson KJ, Watson S, Zanato C, Dall\u2019Angelo S, De Nooij JC, Pace-Bonello B, Shenton FC, Sanger HE, et al. (2024) The atypical \u201chippocampal\u201d glutamate receptor coupled to phospholipase D that controls stretch-sensitivity in primary mechanosensory nerve endings is homomeric purely metabotropic GluK2. Exp Physiol 109(1):81\u201399. https:\/\/doi.org\/10.1113\/EP090761","journal-title":"Exp Physiol"},{"key":"5462_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174384","volume":"908","author":"YA Khadrawy","year":"2021","unstructured":"Khadrawy YA, Hosny EN, Magdy M, Mohammed HS (2021) Antidepressant effects of curcumin-coated iron oxide nanoparticles in a rat model of depression. Eur J Pharmacol 908:174384. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174384","journal-title":"Eur J Pharmacol"},{"key":"5462_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120670","volume":"603","author":"S Rubab","year":"2021","unstructured":"Rubab S, Naeem K, Rana I, Khan N, Afridi M, Ullah I, Shah FA, Sarwar S et al (2021) Enhanced neuroprotective and antidepressant activity of curcumin-loaded nanostructured lipid carriers in lipopolysaccharide-induced depression and anxiety rat model. Int J Pharm 603:120670. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120670","journal-title":"Int J Pharm"},{"key":"5462_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/foods6100092","author":"SJ Hewlings","year":"2017","unstructured":"Hewlings SJ, Kalman DS (2017) Curcumin: a review of its effects on human health. Foods. https:\/\/doi.org\/10.3390\/foods6100092","journal-title":"Foods"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05462-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05462-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05462-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T07:46:52Z","timestamp":1763711212000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05462-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5462"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05462-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"125"}}